Global Cytology and HPV Testing Supply, Demand and Key Producers, 2023-2029

Description

The global Cytology and HPV Testing market size is expected to reach $ 6810.1 million by 2029, rising at a market growth of 7.2% CAGR during the forecast period (2023-2029).

Global key players of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, etc. The top four players hold a share over 40%. North America is the largest market, has a share about 41%, followed by Europe, and Asia-Pacific, with share 26% and 22%, separately. In terms of product type, Consumables is the largest segment, occupied for a share of 58%, and in terms of application, Hospitals & Clinics has a share about 58%.

Cytology Testing, taking the exfoliated cells of the cervix and vagina to determine the possibility of cervical and vaginal precancerous lesions. And HPV Testing is to screen viruses, detect whether there is human papillomavirus in vaginal secretions, especially high-risk human papillomavirus; Cytology Testing has high specificity but poor sensitivity, HPV Testing has strong sensitivity but poor specificity; HPV Testing It can be used as an effective supplement to Cytology Testing, and the combined screening of the two is conducive to improving screening efficiency and increasing the accuracy of Hospitals & Clinics.

This report studies the global Cytology and HPV Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cytology and HPV Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cytology and HPV Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cytology and HPV Testing total market, 2018-2029, (USD Million)
Global Cytology and HPV Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cytology and HPV Testing total market, key domestic companies and share, (USD Million)
Global Cytology and HPV Testing revenue by player and market share 2018-2023, (USD Million)
Global Cytology and HPV Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Cytology and HPV Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cytology and HPV Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics and Abbott, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cytology and HPV Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cytology and HPV Testing Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cytology and HPV Testing Market, Segmentation by Type
    Instruments
    Consumables
    Services

Global Cytology and HPV Testing Market, Segmentation by Application
    Hospitals & Clinics
    Laboratories
    Others

Companies Profiled:
    Thermo Fisher Scientific
    Roche Diagnostics
    QIAGEN
    Bio-rad
    Hologic
    BD
    Hybribio
    KingMed Diagnostics
    Abbott
    bioMérieux
    Cepheid
    BGI Group
    Seegene
    Daan Gene

Key Questions Answered
1. How big is the global Cytology and HPV Testing market?
2. What is the demand of the global Cytology and HPV Testing market?
3. What is the year over year growth of the global Cytology and HPV Testing market?
4. What is the total value of the global Cytology and HPV Testing market?
5. Who are the major players in the global Cytology and HPV Testing market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cytology and HPV Testing Introduction
    1.2 World Cytology and HPV Testing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cytology and HPV Testing Total Market by Region (by Headquarter Location)
        1.3.1 World Cytology and HPV Testing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cytology and HPV Testing Market Size (2018-2029)
        1.3.3 China Cytology and HPV Testing Market Size (2018-2029)
        1.3.4 Europe Cytology and HPV Testing Market Size (2018-2029)
        1.3.5 Japan Cytology and HPV Testing Market Size (2018-2029)
        1.3.6 South Korea Cytology and HPV Testing Market Size (2018-2029)
        1.3.7 ASEAN Cytology and HPV Testing Market Size (2018-2029)
        1.3.8 India Cytology and HPV Testing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cytology and HPV Testing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cytology and HPV Testing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cytology and HPV Testing Consumption Value (2018-2029)
    2.2 World Cytology and HPV Testing Consumption Value by Region
        2.2.1 World Cytology and HPV Testing Consumption Value by Region (2018-2023)
        2.2.2 World Cytology and HPV Testing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cytology and HPV Testing Consumption Value (2018-2029)
    2.4 China Cytology and HPV Testing Consumption Value (2018-2029)
    2.5 Europe Cytology and HPV Testing Consumption Value (2018-2029)
    2.6 Japan Cytology and HPV Testing Consumption Value (2018-2029)
    2.7 South Korea Cytology and HPV Testing Consumption Value (2018-2029)
    2.8 ASEAN Cytology and HPV Testing Consumption Value (2018-2029)
    2.9 India Cytology and HPV Testing Consumption Value (2018-2029)

3 World Cytology and HPV Testing Companies Competitive Analysis
    3.1 World Cytology and HPV Testing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cytology and HPV Testing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cytology and HPV Testing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cytology and HPV Testing in 2022
    3.3 Cytology and HPV Testing Company Evaluation Quadrant
    3.4 Cytology and HPV Testing Market: Overall Company Footprint Analysis
        3.4.1 Cytology and HPV Testing Market: Region Footprint
        3.4.2 Cytology and HPV Testing Market: Company Product Type Footprint
        3.4.3 Cytology and HPV Testing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cytology and HPV Testing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cytology and HPV Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cytology and HPV Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cytology and HPV Testing Consumption Value Comparison
        4.2.1 United States VS China: Cytology and HPV Testing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cytology and HPV Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cytology and HPV Testing Companies and Market Share, 2018-2023
        4.3.1 United States Based Cytology and HPV Testing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cytology and HPV Testing Revenue, (2018-2023)
    4.4 China Based Companies Cytology and HPV Testing Revenue and Market Share, 2018-2023
        4.4.1 China Based Cytology and HPV Testing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cytology and HPV Testing Revenue, (2018-2023)
    4.5 Rest of World Based Cytology and HPV Testing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cytology and HPV Testing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cytology and HPV Testing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cytology and HPV Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Instruments
        5.2.2 Consumables
        5.2.3 Services
    5.3 Market Segment by Type
        5.3.1 World Cytology and HPV Testing Market Size by Type (2018-2023)
        5.3.2 World Cytology and HPV Testing Market Size by Type (2024-2029)
        5.3.3 World Cytology and HPV Testing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cytology and HPV Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals & Clinics
        6.2.2 Laboratories
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Cytology and HPV Testing Market Size by Application (2018-2023)
        6.3.2 World Cytology and HPV Testing Market Size by Application (2024-2029)
        6.3.3 World Cytology and HPV Testing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Details
        7.1.2 Thermo Fisher Scientific Major Business
        7.1.3 Thermo Fisher Scientific Cytology and HPV Testing Product and Services
        7.1.4 Thermo Fisher Scientific Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Thermo Fisher Scientific Recent Developments/Updates
        7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.2 Roche Diagnostics
        7.2.1 Roche Diagnostics Details
        7.2.2 Roche Diagnostics Major Business
        7.2.3 Roche Diagnostics Cytology and HPV Testing Product and Services
        7.2.4 Roche Diagnostics Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Roche Diagnostics Recent Developments/Updates
        7.2.6 Roche Diagnostics Competitive Strengths & Weaknesses
    7.3 QIAGEN
        7.3.1 QIAGEN Details
        7.3.2 QIAGEN Major Business
        7.3.3 QIAGEN Cytology and HPV Testing Product and Services
        7.3.4 QIAGEN Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 QIAGEN Recent Developments/Updates
        7.3.6 QIAGEN Competitive Strengths & Weaknesses
    7.4 Bio-rad
        7.4.1 Bio-rad Details
        7.4.2 Bio-rad Major Business
        7.4.3 Bio-rad Cytology and HPV Testing Product and Services
        7.4.4 Bio-rad Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bio-rad Recent Developments/Updates
        7.4.6 Bio-rad Competitive Strengths & Weaknesses
    7.5 Hologic
        7.5.1 Hologic Details
        7.5.2 Hologic Major Business
        7.5.3 Hologic Cytology and HPV Testing Product and Services
        7.5.4 Hologic Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Hologic Recent Developments/Updates
        7.5.6 Hologic Competitive Strengths & Weaknesses
    7.6 BD
        7.6.1 BD Details
        7.6.2 BD Major Business
        7.6.3 BD Cytology and HPV Testing Product and Services
        7.6.4 BD Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 BD Recent Developments/Updates
        7.6.6 BD Competitive Strengths & Weaknesses
    7.7 Hybribio
        7.7.1 Hybribio Details
        7.7.2 Hybribio Major Business
        7.7.3 Hybribio Cytology and HPV Testing Product and Services
        7.7.4 Hybribio Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Hybribio Recent Developments/Updates
        7.7.6 Hybribio Competitive Strengths & Weaknesses
    7.8 KingMed Diagnostics
        7.8.1 KingMed Diagnostics Details
        7.8.2 KingMed Diagnostics Major Business
        7.8.3 KingMed Diagnostics Cytology and HPV Testing Product and Services
        7.8.4 KingMed Diagnostics Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 KingMed Diagnostics Recent Developments/Updates
        7.8.6 KingMed Diagnostics Competitive Strengths & Weaknesses
    7.9 Abbott
        7.9.1 Abbott Details
        7.9.2 Abbott Major Business
        7.9.3 Abbott Cytology and HPV Testing Product and Services
        7.9.4 Abbott Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Abbott Recent Developments/Updates
        7.9.6 Abbott Competitive Strengths & Weaknesses
    7.10 bioMérieux
        7.10.1 bioMérieux Details
        7.10.2 bioMérieux Major Business
        7.10.3 bioMérieux Cytology and HPV Testing Product and Services
        7.10.4 bioMérieux Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 bioMérieux Recent Developments/Updates
        7.10.6 bioMérieux Competitive Strengths & Weaknesses
    7.11 Cepheid
        7.11.1 Cepheid Details
        7.11.2 Cepheid Major Business
        7.11.3 Cepheid Cytology and HPV Testing Product and Services
        7.11.4 Cepheid Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Cepheid Recent Developments/Updates
        7.11.6 Cepheid Competitive Strengths & Weaknesses
    7.12 BGI Group
        7.12.1 BGI Group Details
        7.12.2 BGI Group Major Business
        7.12.3 BGI Group Cytology and HPV Testing Product and Services
        7.12.4 BGI Group Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 BGI Group Recent Developments/Updates
        7.12.6 BGI Group Competitive Strengths & Weaknesses
    7.13 Seegene
        7.13.1 Seegene Details
        7.13.2 Seegene Major Business
        7.13.3 Seegene Cytology and HPV Testing Product and Services
        7.13.4 Seegene Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Seegene Recent Developments/Updates
        7.13.6 Seegene Competitive Strengths & Weaknesses
    7.14 Daan Gene
        7.14.1 Daan Gene Details
        7.14.2 Daan Gene Major Business
        7.14.3 Daan Gene Cytology and HPV Testing Product and Services
        7.14.4 Daan Gene Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Daan Gene Recent Developments/Updates
        7.14.6 Daan Gene Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cytology and HPV Testing Industry Chain
    8.2 Cytology and HPV Testing Upstream Analysis
    8.3 Cytology and HPV Testing Midstream Analysis
    8.4 Cytology and HPV Testing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cytology and HPV Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cytology and HPV Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cytology and HPV Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cytology and HPV Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cytology and HPV Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cytology and HPV Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cytology and HPV Testing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cytology and HPV Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cytology and HPV Testing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cytology and HPV Testing Players in 2022
    Table 12. World Cytology and HPV Testing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cytology and HPV Testing Company Evaluation Quadrant
    Table 14. Head Office of Key Cytology and HPV Testing Player
    Table 15. Cytology and HPV Testing Market: Company Product Type Footprint
    Table 16. Cytology and HPV Testing Market: Company Product Application Footprint
    Table 17. Cytology and HPV Testing Mergers & Acquisitions Activity
    Table 18. United States VS China Cytology and HPV Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cytology and HPV Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cytology and HPV Testing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cytology and HPV Testing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cytology and HPV Testing Revenue Market Share (2018-2023)
    Table 23. China Based Cytology and HPV Testing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cytology and HPV Testing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cytology and HPV Testing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cytology and HPV Testing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cytology and HPV Testing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cytology and HPV Testing Revenue Market Share (2018-2023)
    Table 29. World Cytology and HPV Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cytology and HPV Testing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cytology and HPV Testing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cytology and HPV Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cytology and HPV Testing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cytology and HPV Testing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 36. Thermo Fisher Scientific Major Business
    Table 37. Thermo Fisher Scientific Cytology and HPV Testing Product and Services
    Table 38. Thermo Fisher Scientific Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Thermo Fisher Scientific Recent Developments/Updates
    Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 41. Roche Diagnostics Basic Information, Area Served and Competitors
    Table 42. Roche Diagnostics Major Business
    Table 43. Roche Diagnostics Cytology and HPV Testing Product and Services
    Table 44. Roche Diagnostics Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Roche Diagnostics Recent Developments/Updates
    Table 46. Roche Diagnostics Competitive Strengths & Weaknesses
    Table 47. QIAGEN Basic Information, Area Served and Competitors
    Table 48. QIAGEN Major Business
    Table 49. QIAGEN Cytology and HPV Testing Product and Services
    Table 50. QIAGEN Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. QIAGEN Recent Developments/Updates
    Table 52. QIAGEN Competitive Strengths & Weaknesses
    Table 53. Bio-rad Basic Information, Area Served and Competitors
    Table 54. Bio-rad Major Business
    Table 55. Bio-rad Cytology and HPV Testing Product and Services
    Table 56. Bio-rad Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Bio-rad Recent Developments/Updates
    Table 58. Bio-rad Competitive Strengths & Weaknesses
    Table 59. Hologic Basic Information, Area Served and Competitors
    Table 60. Hologic Major Business
    Table 61. Hologic Cytology and HPV Testing Product and Services
    Table 62. Hologic Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Hologic Recent Developments/Updates
    Table 64. Hologic Competitive Strengths & Weaknesses
    Table 65. BD Basic Information, Area Served and Competitors
    Table 66. BD Major Business
    Table 67. BD Cytology and HPV Testing Product and Services
    Table 68. BD Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. BD Recent Developments/Updates
    Table 70. BD Competitive Strengths & Weaknesses
    Table 71. Hybribio Basic Information, Area Served and Competitors
    Table 72. Hybribio Major Business
    Table 73. Hybribio Cytology and HPV Testing Product and Services
    Table 74. Hybribio Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Hybribio Recent Developments/Updates
    Table 76. Hybribio Competitive Strengths & Weaknesses
    Table 77. KingMed Diagnostics Basic Information, Area Served and Competitors
    Table 78. KingMed Diagnostics Major Business
    Table 79. KingMed Diagnostics Cytology and HPV Testing Product and Services
    Table 80. KingMed Diagnostics Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. KingMed Diagnostics Recent Developments/Updates
    Table 82. KingMed Diagnostics Competitive Strengths & Weaknesses
    Table 83. Abbott Basic Information, Area Served and Competitors
    Table 84. Abbott Major Business
    Table 85. Abbott Cytology and HPV Testing Product and Services
    Table 86. Abbott Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Abbott Recent Developments/Updates
    Table 88. Abbott Competitive Strengths & Weaknesses
    Table 89. bioMérieux Basic Information, Area Served and Competitors
    Table 90. bioMérieux Major Business
    Table 91. bioMérieux Cytology and HPV Testing Product and Services
    Table 92. bioMérieux Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. bioMérieux Recent Developments/Updates
    Table 94. bioMérieux Competitive Strengths & Weaknesses
    Table 95. Cepheid Basic Information, Area Served and Competitors
    Table 96. Cepheid Major Business
    Table 97. Cepheid Cytology and HPV Testing Product and Services
    Table 98. Cepheid Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Cepheid Recent Developments/Updates
    Table 100. Cepheid Competitive Strengths & Weaknesses
    Table 101. BGI Group Basic Information, Area Served and Competitors
    Table 102. BGI Group Major Business
    Table 103. BGI Group Cytology and HPV Testing Product and Services
    Table 104. BGI Group Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. BGI Group Recent Developments/Updates
    Table 106. BGI Group Competitive Strengths & Weaknesses
    Table 107. Seegene Basic Information, Area Served and Competitors
    Table 108. Seegene Major Business
    Table 109. Seegene Cytology and HPV Testing Product and Services
    Table 110. Seegene Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Seegene Recent Developments/Updates
    Table 112. Daan Gene Basic Information, Area Served and Competitors
    Table 113. Daan Gene Major Business
    Table 114. Daan Gene Cytology and HPV Testing Product and Services
    Table 115. Daan Gene Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Cytology and HPV Testing Upstream (Raw Materials)
    Table 117. Cytology and HPV Testing Typical Customers
List of Figure
    Figure 1. Cytology and HPV Testing Picture
    Figure 2. World Cytology and HPV Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cytology and HPV Testing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cytology and HPV Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cytology and HPV Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cytology and HPV Testing Revenue (2018-2029) & (USD Million)
    Figure 13. Cytology and HPV Testing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cytology and HPV Testing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cytology and HPV Testing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cytology and HPV Testing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cytology and HPV Testing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cytology and HPV Testing Markets in 2022
    Figure 27. United States VS China: Cytology and HPV Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cytology and HPV Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cytology and HPV Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cytology and HPV Testing Market Size Market Share by Type in 2022
    Figure 31. Instruments
    Figure 32. Consumables
    Figure 33. Services
    Figure 34. World Cytology and HPV Testing Market Size Market Share by Type (2018-2029)
    Figure 35. World Cytology and HPV Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Cytology and HPV Testing Market Size Market Share by Application in 2022
    Figure 37. Hospitals & Clinics
    Figure 38. Laboratories
    Figure 39. Others
    Figure 40. Cytology and HPV Testing Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Thermo Fisher Scientific
Roche Diagnostics
QIAGEN
Bio-rad
Hologic
BD
Hybribio
KingMed Diagnostics
Abbott
bioMérieux
Cepheid
BGI Group
Seegene
Daan Gene